Skip to main content

Advertisement

SpringerLink
Log in

The Value of HPV-HR DNA Testing During the Follow-Up After Treatment of CIN3/AIS

  • Research
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Nuovo J, Melnikow J, Willan AR, Chan BK (2000) Treatment outcomes for squamous intraepithelial lesions. Int J Gynaecol Obstet 68(1):25–33

    Article  CAS  PubMed  Google Scholar 

  2. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G et al (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 20(30 Suppl 5):F88–99

    Article  Google Scholar 

  3. MartinHirsch PL, Paraskevaidis E, Kitchener H (2000) Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2000;(2):CD001318

  4. Bae JH, Kim CJ, Park TC, Namkoong SE, Park JS (2007) Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer 17(6):1271–7

    Article  CAS  PubMed  Google Scholar 

  5. Prato B, Ghelardi A, Gadducci A, Marchetti I, Di Cristofano C, Di Coscio G et al (2008) Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions. Int J Gynecol Cancer 18(1):90–4

    Article  CAS  PubMed  Google Scholar 

  6. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M et al (2003) Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90(2):358–65

    Article  PubMed  Google Scholar 

  7. Ovanin-Rakić A, Pajtler M, Stanković T et al (2003) Classification of cytologic cervical smears ‘’Zagreb 2002”. Modification of classifications ‘’Zagreb 1991 and NCI Bethesda system 2001”. Gynaecol Perinatol 12:148–53

    Google Scholar 

  8. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK (2013) Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis 17(5 Suppl 1):S78–84. doi:10.1097/LGT.0b013e31828543c5

    Article  PubMed Central  PubMed  Google Scholar 

  9. Almog B, Gamzu R, Bornstein J, Levin I, Fainaru O, Niv J, Lessing JB, Bar-Am A (2003) Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3. Br J Cancer Jul 7;89(1):109–12.

  10. Coupe VM, Berkhof J, Verheijen RH, Meijer CJ (2007) Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia. BJOG 114(4):416–24

    Article  CAS  PubMed  Google Scholar 

  11. Gök M, Coupé VM, Berkhof J, Verheijen RH, Helmerhorst TJ, Hogewoning CJ et al (2007) HPV16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol 104(2):273–5

    Article  PubMed  Google Scholar 

  12. Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117(2 Suppl):S5–10. doi:10.1016/j.ygyno.2010.01.024

    Article  PubMed  Google Scholar 

  13. Du R, Meng W, Chen ZF, Zhang Y, Chen SY, Ding Y (2013) Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 34(6):548–51

    CAS  PubMed  Google Scholar 

  14. Zielinski GD, Bais AG, Helmerhorst TJ, Verheijen RH, de Schipper FA, Snijders PJ, Voorhorst FJ, van Kemenade FJ, Rozendaal L, Meijer CJ (2004) HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 59(7):543–53

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, Clinical Hospital Center Zagreb, Department of Obstetrics and Gynecology, University of Zagreb, Petrova 13, 10000, Zagreb, Croatia

    Maja Banović, Vladimir Banović, Ivan Babić & Slavko Orešković

  2. School of Medicine, Clinical Hospital Center Zagreb, Department of Pathology and Cytology, University of Zagreb, Zagreb, Croatia

    Vesna Mahovlić & Damir Babić

  3. School of Medicine, Department of Pathology, University of Zagreb, Zagreb, Croatia

    Kristina Meljanac Salopek

Authors
  1. Maja Banović
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vesna Mahovlić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristina Meljanac Salopek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vladimir Banović
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ivan Babić
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Slavko Orešković
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Damir Babić
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maja Banović.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Banović, M., Mahovlić, V., Salopek, K.M. et al. The Value of HPV-HR DNA Testing During the Follow-Up After Treatment of CIN3/AIS. Pathol. Oncol. Res. 21, 613–617 (2015). https://doi.org/10.1007/s12253-014-9865-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-014-9865-8

Keywords

Search

Navigation